LXR agonist 4
LXR agonist 4 is a selective LXR inverse agonist with IC50 values of 7.6 (LXRα) and 2.9 μM (LXRβ), respectively. LXR agonist 4 exhibits selectivity over RORα and FXR. LXR agonist 4 robustly suppresses SREBP1c expression without altering ABCA1 or APOE. LXR agonist 4 displays antilipogenic properties and resolves fatty acid-induced steatosis. LXR agonist 4 can be used for the research of atherosclerosis and metabolic dysfunction-associated steatotic liver disease (MASLD) [1].
Product Specifications
UNSPSC
12352100
Target
LXR
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Field of Research
Endocrinology; Metabolic Disease; Cardiovascular Disease
Smiles
CS(C1=CC=CC(C2=CC=C(C=C2)CN(CC(C3=CC=CC=C3)C4=CC=CC=C4)CC5=CC=CC(C(F)(F)F)=C5Cl)=C1)(=O)=O
Molecular Formula
C36H31ClF3NO2S
Molecular Weight
634.15
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD11c (Dendritic Cell Marker) (ITGAX/1284), CF405S conjugate, 0.1mg/mL
![Nkx3.1 (NKX3-1) Mouse Monoclonal Antibody [Clone ID: 4H4]](https://cdn.genprice.uk/products/937/68dd189a061270361e8fbdd6/imageurl/am06425su-n.webp)
Nkx3.1 (NKX3-1) Mouse Monoclonal Antibody [Clone ID: 4H4]
